首页> 外文OA文献 >ATIM-28. PHASE II TRIAL OF AV-GBM-1 (AUTOLOGOUS DENDRITIC CELLS LOADED WITH TUMOR ASSOCIATED ANTIGENS) AS ADJUNCTIVE THERAPY FOLLOWING SURGERY PLUS CONCURRENT CHEMORADIATION IN NEWLY DIAGNOSED GBM PATIENTS

【2h】

ATIM-28. PHASE II TRIAL OF AV-GBM-1 (AUTOLOGOUS DENDRITIC CELLS LOADED WITH TUMOR ASSOCIATED ANTIGENS) AS ADJUNCTIVE THERAPY FOLLOWING SURGERY PLUS CONCURRENT CHEMORADIATION IN NEWLY DIAGNOSED GBM PATIENTS

机译：ATIM-28。 AV-GBM-1（肿瘤相关抗原的自体树突细胞的AV-GBM-1（用肿瘤相关抗原的自体树突细胞）作为辅助治疗，在新诊断的GBM患者中加上并发趋化性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Daniela Bota; Thomas Taylor; David Picconi; Christopher Duma; Robert Aiken; Renato LaRocca; Kong Xiao-Tang; Beverly Fu; Mohamad Alsharif; Candace Hsieh; Gabriel Nistor; Robert Dillman;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. 787?Phase III clinical trial to test the safety and efficacy of autologous tumor lysate-loaded dendritic cells in patients with newly diagnosed glioblastoma [J] . Marnix Bosch, Linda Liau, Keyoumars Ashkan Journal for ImmunoTherapy of Cancer . 2020,第Suppla3期

机译：787年？III期临床试验，以测试新诊断的胶质母细胞瘤患者自体肿瘤裂解物的树突细胞的安全性和有效性
2. Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with metastatic melanoma: final report. [J] . Dillman RO, Selvan SR, Schiltz PM Cancer biotherapy and radiopharmaceuticals . 2009,第3期

机译：在转移性黑素瘤患者中，树突状细胞负载自更新的，增殖的自体肿瘤细胞作为患者特异性抗肿瘤疫苗的抗原的II期试验：最终报告。
3. A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients [J] . Susana Inogés, Sonia Tejada, Ascensión López-Díaz Cerio, Journal of Translational Medicine . 2017,第1期

机译：新诊断的胶质母细胞瘤患者接受荧光引导手术后自体树突状细胞疫苗接种和放化疗的II期试验
4. RISK-ADAPTED INTRAVENOUS MELPHALAN WITH ADJUVANT THALIDOMIDE AND DEXAMETHASONE FOR NEWLY DIAGNOSED UNTREATED PATIENTS WITH SYSTEMIC AL AMYLOIDOSIS: INTERIM REPORT OF A PHASE II TRIAL [C] . RL Comenzo, P Zhou, L Reich, International Symposium on Amyloidosis . 2005

机译：风险适应的静脉内莫尔甘蔗用佐剂沙利度胺和地塞米松，用于新诊断的未经治疗的全身淀粉样蛋白症患者：II期试验的中期报告
5. ATIM-28. PHASE II TRIAL OF AV-GBM-1 (AUTOLOGOUS DENDRITIC CELLS LOADED WITH TUMOR ASSOCIATED ANTIGENS) AS ADJUNCTIVE THERAPY FOLLOWING SURGERY PLUS CONCURRENT CHEMORADIATION IN NEWLY DIAGNOSED GBM PATIENTS [O] . Daniela Bota, Thomas Taylor, David Picconi, 2019

机译：ATIM-28。 AV-GBM-1（肿瘤相关抗原的自体树突细胞的AV-GBM-1（用肿瘤相关抗原的自体树突细胞）作为辅助治疗在新诊断的GBM患者中加上并发趋化性
6. Phase II Trial of Dendritic Cells Loaded with Antigens from Self-Renewing, Proliferating Autologous Tumor Cells as Patient-Specific Antitumor Vaccines in Patients with Metastatic Melanoma: Final Report [O] . Robert O. Dillman, Senthamil R. Selvan, Patric M. Schiltz, 2009

机译：抗原的树突细胞的II期试验从自我更新，激增自体肿瘤细胞作为转移性黑素瘤患者的患者特异性抗肿瘤疫苗：最终报告

ATIM-28. PHASE II TRIAL OF AV-GBM-1 (AUTOLOGOUS DENDRITIC CELLS LOADED WITH TUMOR ASSOCIATED ANTIGENS) AS ADJUNCTIVE THERAPY FOLLOWING SURGERY PLUS CONCURRENT CHEMORADIATION IN NEWLY DIAGNOSED GBM PATIENTS

著录项

引文网络

相似文献

相关主题

期刊订阅